The Galien Foundation has nominated Evidently for the inaugural 2026 Prix Galien Patient First Award, alongside Johnson & Johnson, Merck, Pfizer, Roche, and other leading organizations across pharmaceuticals, biotechnology, medical devices, and health technology.
The Prix Galien awards are widely regarded as the equivalent of the Nobel Prize for healthcare. The Patient First Award is the Foundation's newest, created to recognize initiatives that embed patient voices into care, advance patient-centered quality improvement, and translate research into meaningful improvements in patient outcomes. Winners will be announced on October 29 at the Galien Patient Summit, held at the New York Academy of Medicine.
Nominees are being evaluated by a judging panel that includes Amy Abernethy, MD, PhD, former Principal Deputy Commissioner of the FDA; Margaret Hamburg, MD, former FDA Commissioner; Janet Woodcock, MD, former Principal Deputy Commissioner of the FDA and longtime Director of the Center for Drug Evaluation and Research; and David Fajgenbaum, MD, MBA, MSc, of Every Cure and the University of Pennsylvania.
Every patient carries a clinical history built across a lifetime of care: scanned documents, faxes from outside facilities, imaging reports, records from prior health systems, years of clinical notes across dozens of providers. That history is the most complete record of who they are medically. In most health systems, the vast majority of it is inaccessible at the point of care. Clinicians make decisions from what they can find in the time they have, not from what the record actually contains.
For patients who cannot speak for themselves, the consequences are immediate. At one of our partner health systems, a child in organ failure faced an ECMO decision with 50% survival odds. The child's medical history spanned years of encounters across multiple care settings. No clinician could synthesize all of it at the bedside during a crisis. Our platform's analysis of the full longitudinal record changed the treatment plan. The child avoided ECMO, came off life support, and was discharged home.
We built Evidently on the recognition that the patient's own clinical record is their most durable advocate, even when they can't articulate what matters in the moment. Every data point in the chart could be the one that changes care. We built the platform to read it all, so the care team doesn't have to choose which parts matter. Because all of it matters.
